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Abstract
Joint arthroplasty had revolutionized the outcome of 
orthopaedic surgery. Extensive and collaborative work 
of many innovator surgeons had led to the development 
of durable bearing surfaces, yet no single material 
is considered absolutely perfect. Generation of wear 
debris from any part of the prosthesis is unavoidable. 
Implant loosening secondary to osteolysis is the most 
common mode of failure of arthroplasty. Osteolysis is 
the resultant of complex contribution of the generated 
wear debris and the mechanical instability of the 
prosthetic components. Roughly speaking, all orthopedic 
biomaterials may induce a universal biologic host 
response to generated wear débris with little specific 
characteristics for each material; but some debris has 
been shown to be more cytotoxic than others. Prosthetic 
wear debris induces an extensive biological cascade of 
adverse cellular responses, where macrophages are the 
main cellular type involved in this hostile inflammatory 
process. Macrophages cause osteolysis indirectly 
by releasing numerous chemotactic inflammatory 
mediators, and directly by resorbing bone with their 
membrane microstructures. The bio-reactivity of wear 
particles depends on two major elements: particle 
characteristics (size, concentration and composition) 
and host characteristics. While any particle type 
may enhance hostile cellular reaction, cytological 
examination demonstrated that more than 70% of the 
debris burden is constituted of polyethylene particles. 
Comprehensive understanding of the intricate process 
of osteolysis is of utmost importance for future 
development of therapeutic modalities that may delay 
or prevent the disease progression.
Key words: Debris; Adverse reaction; Osteolysis; Macro-
phages; Cytokines; Chemotaxis; Polyethylene; Phagocytosis
© The Author(s) 2015. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: After a comprehensive review of joint 
arthroplasty history, this article outlines the fundamental 
pathophysiology of the debris-induced biological reaction 
common to all particles types. Furthermore, specific 
characteristics of polyethylene, metal, ceramic, and 
polymethylmethacrylate particles are stated separately 
with their associated clinical relevance. Lastly, future 
therapeutic strategies to down-regulate periprosthetic 
osteolysis are enumerated, including anti-inflammatory 
agents used to modulate the cytokines release, anti-
osteolytic agents used to disintegrate osteoclasts 
morphology, and antioxidants used to demolish the free 
oxygen radicals produced by the activated macrophages. 
The reader will find an extensive literature review 
encompassing all aspects of the debris-induced hostile 
cellular reaction.
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JOINT ARTHROPLASTY HISTORICAL 
REVIEW 
As stated by the famous French philosopher of science, 
Auguste COMTE (1798-1857), we cannot completely 
know a science without knowing its history.
The first implanted total joint arthroplasty goes 
back to 1890 where the German surgeon “Themistocles 
Gluck”[1] performed in Berlin a total ivory prosthesis 
on the tuberculous knee of a 17-year-old woman. 
Professor Gluck, whom revolutionary effort was 
dismissed during his lifetime, was also the first surgeon 
to use bone cement, about 65 years before Sir John 
Charnley[2].
Afterward, many biological (fascia lata grafts; pork 
bladder submucosa; skin) and inorganic materials 
were used as interpositional layer in an attempt to 
resurface the arthritic joints: In 1885, Léopold Ollier 
used adipose tissue and in 1912, Jones used gold foil 
to perform their “interpositional arthroplasty”.
In 1922, the English surgeon Hey-Groves replaced 
the femoral head by an ivory sphere of same caliber 
with satisfactory result up to 4 years only. In 1923, the 
American surgeon “Marius Smith-Petersen” introduced 
the concept of “mold arthroplasty”[1] where he chose 
glass as material of his first mold after he removed 
a glass foreign body from a patient’s back and found 
it surrounded by a synovial membrane. Many other 
inorganic materials were tried (Pyrex, Bakelite, 
viscaloid...) without success either because of their 
fragility or the toxicity of their debris.
In 1936, Venable et al[3] discovered the single 
electrically inert metal alloy, “Vitallium”, composed 
of cobalt (60%), chromium (20%) and molybdenum 
(5%). Subsequently in 1940, Austin MOORE and 
Harold BOHLMAN placed the “first metal hip joint” 
made of Vitallium, in United States, Columbia, South 
Carolina: one piece femoral head and stem inserted in 
the intra-medullary canal.
In 1946, the 2 French brothers JUDET conceived 
the “Plexiglas” [polymethyl methacrylate (PMMA)] 
femoral sphere attached to a short stem, replacing 
the hip arthrodesis by hip prosthesis[2]. A short-lived 
good result was achieved since the PMMA material was 
extremely fragile and yielded tremendous wear debris.
In 1951 at Norwich (United Kingdom), McKee 
was the first surgeon to replace both sides of the 
hip articular surfaces using a metal-on-metal (MOM) 
prosthesis. Sir John Charnley is considered the “father 
of modern arthroplasty” where in 1960 at Manchester 
(United Kingdom), he pioneered the concept of 
“low friction arthroplasty”, called like so because he 
promoted the use of a small femoral head in order to 
minimize the wear[1]. In 1962, he finalized his totally 
cemented prosthesis: a cemented polyethylene (PE) 
acetabular component and “monoblock” (one-piece) 
cemented femoral stem with 22 mm femoral head.
The initial work of all these surgeons focused on the 
design and fixation method of the implants. Once this 
goal has been achieved with Charnley, more attention 
was drawn toward the longevity of the prosthesis 
where “aseptic loosing” started to be noted since the 
early 1960’s[4]. Implant aseptic loosening is the result of 
the complex intrication of fibrous membrane formation, 
peri-prosthetic bone resorption and inflammatory 
cytokines production[5].
Based on the extensive research work performed 
throughout the historical existence of arthroplasty, 
especially that of the hip joint, we were able to conclude 
that an extended longevity of an artificial joint depends 
mainly on 3 fundamental factors: (1) the durability 
of implant fixation; (2) the wear rate of the bearing 
surfaces; and (3) the accuracy of the surgical technique 
of prosthesis implantation. 
This review article will discuss the wear factor 
stating the different types of generated prosthetic 
debris (PE, PMMA, metal, and ceramic) along with their 
specific characteristics (if present) and subsequent 
host biological reactions. The current knowledge of the 
adverse biologic reaction induced by different types of 
wear debris derives from the histo-pathologic analysis 
of the retrieved peri-prosthetic tissue during revision 
surgery, from genetic studies or from animal models 
studies.
At present, more than sixty years after the 
pioneering of the modern notions of arthroplasty, 
that underwent an active perpetual progress during 
this whole period, tens of thousands of hip and knee 
replacements are performed each year in United States 
and Europe[1,6]. “According to the Agency for Healthcare 
Research and Quality, more than 285000 total hip 
arthroplasties (THA) and more than 600000 knee 
arthroplasties are performed each year in the United 
States” (www.AAOS.org). According to the national 
joint registry (www.njrcentre.org.uk), approximately 
160000 total hip and knee replacement procedures 
are performed each year in England and Wales, with 
the same number of replaced hip and knee joints. 
Based on the absolute number of THA performed per 
100.000 inhabitants, Germany is the first on the list 
(296 THA/100.000 residents), followed by Switzerland 
(287/100.000) and Belgium (240/100.000)[6]. In 
United States and United Kingdom, 184 and 194 THAs 
respectively are performed per 100.000 inhabitants[6]. 
The number of annually performed arthroplasty is 
worldwide steadily increasing with time.
Building on the brilliant success attained, especially 
with (THA), the indication of joint replacement surgery 
was enlarged to include young active patients[1,7] 
suffering from disabling joint diseases, raising the 
problem of bearing surfaces wear that induces a chronic 
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inflammatory reaction leading to osteolysis[4,8] which 
accounts for the greatest majority of revision surgery 
that can be sometimes extensive and complicated. 
In addition, with the advances accomplished in the 
majority of medical fields, the life expectancy of the 
general population is lengthened, with more physically 
active elderly individuals being candidates for total joint 
replacements[8] with higher stresses exerted on the 
bearing surfaces for longer periods of time.
For THA, different types of bearing surfaces are 
available nowadays and can be broadly classified into 
2 groups: hard-on-hard surfaces including ceramic-on-
ceramic (COC) and MOM, and hard-on-soft surfaces 
including metal-on-polyethylene (MOP) and ceramic-
on-polyethylene (COP). The most widely used bearings 
are metal-on-polyethylene that showed, since its 
introduction with Charnley prosthesis, good, cost-
effective and predictable outcomes for decades[1] 
with concordant results whatever school or country is 
considered: 85% survival rate at 25 years and 78% 
at 35 years of follow-up[6]. Each couple of bearing 
surfaces has its advantages and drawbacks. It is 
incontestable that the development of these materials 
knew a marvelous evolution during the second half of 
the 20th century, but yet none can be considered to be 
absolutely perfect.
PERI-PROSTHETIC OSTEOLYSIS: BASIC 
SCIENCE
Total joint arthroplasty is considered one of the most 
prosperous branches of Orthopaedic surgery, where the 
damaged and painful articular surfaces are substituted 
by artificial anatomically-shaped components, amelio-
rating the patient quality of life by providing painless 
and unrestricted range of motion of the affected joint. 
Total hip and total knee replacement surgeries are part 
of the “top 5” surgical interventions in Orthopaedic 
surgery, alongside with carpal tunnel decompression, 
arthroscopic meniscal surgery and hardware removal[6]. 
However, as published by numerous long-term studies, 
all total joint replacements end up by loosening[4,9-14] 
with different time-frame longevity for every joint of 
the body.
The fact that endurance of arthroplasty is not 
everlasting is due to osteolysis of the bone surrounding 
the implants; it get established gradually as wear 
débris (mainly PE particles) are continuously produced 
by the mobile articulating bearings[5,15], increasing 
with time[4,9,14,16], with “aseptic loosening” being the 
end-point of the bone loss. While it is uncontestable 
that aseptic loosening is the resultant of wear debris 
production, the exact responsible mechanism and 
the risk factors are still ill-defined[14]. Likewise, since 
the adverse biologic reaction to prosthetic debris is 
not yet elucidated from A to Z, no universal definition 
for aseptic loosening can be given[14]. Peri-prosthetic 
osteolysis is rarely limited over many years; most 
likely, it progresses with time and, if unrecognized, can 
lead to extensive bone loss, requiring very complex 
reconstructive revision surgeries with compromised 
long-term outcomes[9].
Willert et al[17] were the first to notice in 1977, 
the hostile biologic effect associated with the wear 
débris, which is characterized by peri-prosthetic bone 
loss. But Salvati et al[18] were the first to describe in 
detail, in 1993, the “debris disease” triggered by PE or 
metallic debris. Aseptic loosening is the most common 
cause of arthroplasty failure representing around 75% 
of cases, with infection (7%), recurrent dislocations 
(6%), and fractures (5%) accounting for the remaining 
reasons for failure[10]. Peri-prosthetic osteolysis may 
be manifested radiographically by radiolucent lines 
which consist mainly of macrophages incorporating 
prosthetic debris[9]. As stated by Ollivere et al[14], once 
osteolysis is manifested radiographically, it will be 
coupled with a more hostile biologic reaction, as it is 
reflected by the increased cytokines levels. Progression 
of the radiographic evidence of peri-prosthetic bone 
loss is a very slow process that is extremely uncommon 
before 5 years after implantation[9]. This disease 
can have completely asymptomatic or symptomatic 
presentations[9]. For this reason, it is extremely important 
to periodically assess the patients radiographically, 
especially 5 to 8 years after implantation, looking for 
subclinical peri-prosthetic osteolysis. Most series have 
reported increased incidence of osteolysis around 10 
years following arthroplasty, but few cases occur before 
10 years interval. Symptomatic osteolysis can be 
manifested by painful loosening and/or fracture.
Foreign bodies particles can be generated from 
any part of the prosthesis: from the articulating 
surfaces or from the bone/implant or bone/cement 
interface[4,19]. These particles accumulate in the joint 
synovial fluid and may, after stimulation of the host 
cellular response, get incorporated in the inner aspect 
of the neo-capsule which is usually formed after joint 
prosthesis insertion[19]. Consequently, granulomas 
(nodules consisting of inflammatory cells phagocytizing 
the foreign bodies) with central necrosis, fibrosis or 
scar tissue can form within the capsule[19,20].
Osteolysis, originally called “cement disease” 
since it was first described after revision of cemented 
prosthesis, is the consequence of the adverse cellular 
host reaction to wear débris that can emanate from 
any interface of the prosthetic implants[4,14]. Roughly 
speaking, all orthopedic biomaterials may induce a 
universal biologic host response to generated wear 
débris with little specific characteristics for each 
material; but some debris has been shown to be more 
cytotoxic than others[5,14,19]. Likewise, peri-prosthetic 
bone loss can occur with any fixation method: cemented 
or cementless prosthesis[4]. The universality of wear 
debris behavior have been challenged recently where 
a study conducted on animals has shown that various 
types of wear particles influence differently the 
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Histiocytes are part of the reticulo-endothelial 
system (AKA lympho-reticular system or mononuclear 
phagocyte system). Different types of histiocytes 
exist including macrophages (which main function is 
phagocytosis), dendritic cells (which main function 
is antigen presentation) and Langerhans cells. Most 
of the research investigating the biological response 
to wear debris has focused on macrophages before 
clarifying the role of other cell types[8]. Foreign body 
giant cells (which are fused macrophages generated in 
response to the presence of a large foreign body) are 
notably present in the osteolytic tissue surrounding 
cemented implants; these cells are considered a 
reaction to the acrylate (cement) fragments[4,19]. All 
these cell types actively interact with each other, 
where for example, fibroblasts trigger the formation 
of foreign body giant cells, and osteoblasts contribute 
to the differentiation and maturation of osteoclasts[5]. 
Wang et al[26] showed that fibroblasts release osteolytic 
enzymes in response to debris exposure, especially 
stromelysin and Collagenase in the presence of Ti 
particles. However the exact role of lymphocytes is still 
debatable where the hypothetical synergism between 
lymphocytes and macrophages in cytokines release 
could not be demonstrated in one study; T-cells at the 
interface membrane may alter the cellular response to 
wear debris[22].
Leukocytes are hematogenous cells produced in the 
bone marrow, are then transported to the blood vessels 
and finally to the concerned host tissue containing 
foreign products, after crossing the endothelial-lining of 
the vessels wall. Hereafter, endothelial cells represent 
an active and essential contributor to the transport 
process allowing the leukocytes to reach the interface 
membrane[5]. In addition to their role in hemostasis, 
endothelial cells play an important role in inflammation 
by synthetizing and releasing von Willebrand factor 
(vWf) from their intracellular granules, “Weibel-Palade 
bodies”, once they are activated or damaged[5]. The 
collagen-binding domains of vWf bind tightly to the 
collagen tissue surrounding the vessels, forming the 
“peri-vascular cotton wool-like cuff” in the synovium-
like interface membrane[5].
Elucidating the specific involvement of each cell 
type was not of great evidence or ease. It was Kadoya 
et al[27] who first reported that, next to the interface 
membrane of aseptically loose implants, bone formation 
was by far more prominent than bone loss; They 
highlighted the presence of osteoblasts in the reactive 
tissue and demonstrated that macrophages, not only 
stimulate bone lysis by releasing cytokines which 
activate osteoclasts, but also have microstructures that 
allow them to resorb the bone actively and directly. 
But actually, it is well known that osteoblasts, beside 
their role in osteo-genesis, produce Receptor activator 
of nuclear factor kappa-B ligand (“RANKL”) and 
macrophage colony stimulating factor (“M-CSF”) that are 
cell membrane receptors involved in bone resorption and 
differentiation and maturation of the osteo-genetic cells 
and that stimulated bone marrow stromal cells may 
play a primordial role in the pathogenesis of debris-
induced aseptic loosening[21].
Histo-pathologically, the peri-prosthetic tissue is 
a fibrous granulomatous tissue constantly composed 
of a complex amalgam of cellular infiltration and 
particulate debris. The cellular component of this tissue 
includes numerous cell types: histiocytes, fibroblasts, 
osteoblasts, osteoclasts, osteo-progenitor cells [adult 
mesenchymal stem cells (MSCs)], synovial cells, 
endothelial cells and less commonly lymphocytes[4,5,8,22]. 
Neutrophils are only found in septic loosening cases[5]. 
Plasma cells and lymphocytes are found even without 
evidence of infection; they constitute a sign of humoral 
immunity defense mechanism[19].
Monocyte/macrophage lineage is the major cell 
type involved in the inflammatory wear-induced peri-
prosthetic osteolysis by their phagocytic role and pro-
inflammatory mediator’s release[5,14,19,22-24]. Macrophages 
are one of the first cells to act where 48 h after 
exposure to debris, their cytoplasm enlarge assuming a 
balloon-like appearance (diameter size increasing from 
10-20 µm to 40-50 µm)[22], and they release different 
inflammatory biomarkers, like tumor necrosis factor 
alpha (TNF-α), monocyte chemotactic protein-1 (MCP-1), 
and macrophage inflammatory protein-1 alpha[14,25]. 
MCP-1 is one of the most important inflammatory 
cytokines, playing a chemotactic role where it recruits 
peripheral monocytes and osteoclasts (that derive 
from the common cell lineage of macrophages)[14,24]. 
Many signaling pathways may stimulate macrophages 
leading to the release of different types of inflammatory 
cytokines[14]. The classical macrophage activation 
pathway (M1) is mainly enhanced by T-helper 1 cells 
(Th 1) and their specific cytokines group, especially 
interferon-Y, which is normally secreted by microbial 
activation. This pathway results chiefly in interleukin-1 
(IL-1) and TNF-α production by the macrophages. The 
alternative macrophage activation pathway (M2), which 
consists of broad spectrum of responses, is mainly 
regulated by Th 2 cytokines, mainly IL-4 and IL-13. This 
pathway activation leads to the secretion of different 
cytokines by the macrophages, like prostaglandin 
E2 (PGE2), as well as to the stimulation of variant 
detrimental cellular reactions, such as the nuclear factor 
kappa-B (NF-κB) apoptotic pathway and the mitogen-
activated protein kinases, an intracellular stress and 
inflammatory signal transduction trail[14].
The alternative macrophage activation pathways, 
which are the culprit pathogenesis mechanisms of 
multiple systemic inflammatory diseases (multiple 
sclerosis, tuberculosis, Gaucher’s disease, athero-
sclerosis), seem to play a major role also in the wear-
induced osteolysis. The knowledge of these alternative 
pathways is still in its infancy; this may be a rational 
explanation behind our failure to reproduce in vitro the 
extremely complicated in vivo osteolysis process.
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release cytokines stimulating osteoclasts formation[5]. In 
fact few studies explored the role of osteoblasts in peri-
prosthetic osteolysis, while numerous studies explored 
osteoclasts that have been always considered central 
to the active bone resorption process[14]. Lohmann et 
al[28] demonstrated that osteoblasts may phagocytize 
prosthetic debris enhancing cytokines expression and 
release. Osteoblasts originate from the differentiation 
and maturation of the osteo-progenitor stem cells 
contained in the periosteum, under the effect of many 
growth factors like platelet-derived growth factors 
(PDGFs), bone morphogenetic proteins (BMPs), 
transforming growth factor beta (TGF-β) and fibroblast 
growth factors (FGFs)[14]. Osteoblasts can be stimulated 
differently according to the type and dose of the culprit 
wear debris[21,28]: low dose of ultra-high molecular 
weight polyethylene (UHMWPE) or PMMA particles (0.63 
mg/mL) displayed strong alkaline phosphatase activity 
while Co-Cr and Ti particles exhibited minimal effects 
on the osteoblasts. UHMWPE exposure down-regulate 
osteoblasts production of collagen type Ⅰ and Ⅲ[14]. 
The generated débris can have one of 2 different 
forms: soluble ions or insoluble particles which aggre-
gate with the serum protein forming protein-particles 
complexes, of different sizes[8,10]. The adverse effect 
of wear debris is primarily manifested locally by 
an aggressive inflammation whose maestro is the 
macrophages[10]. The effect of systemic dissemination 
of wear debris, especially metal and PE debris is 
controversial without established risk of toxicity and 
carcinogenicity to date.
The different orthopedic biomaterial particles, 
when binding to the serum protein, can change their 
conformation causing them to be recognized as foreign 
proteins by T-lymphocytes[22]. To undergo phagocytosis 
or pinocytosis, a particle should have a size inferior to 
10 µm (ranging from 150 nm to 10 µm)[4,8,10]. Once 
ingested by macrophages or other cells, the wear debris 
trigger the host biologic response characterized by the 
release of inflammatory mediators, T-cell activation 
through antigen presentation, oxidative stress and DNA 
damage[10]. Cellular activation (mainly macrophages) 
differs with the engendered form: ions trigger the 
biologic cascade after they are phagocytosed and non-
phagocytosable complexes activate the cell via its 
membrane receptors[8,23]. 
The debris particles can manifest their adverse 
effect either directly by eliciting the biologic cascade 
leading to osteolysis or indirectly by third-body 
mechanism accelerating the polyethylene’s wear once 
they reach the articulation[4,29]. Third body débris (such 
as metallic particles, PMMA cement or even cortical 
bone) can be entrapped between the articulating 
surfaces of the prosthesis causing “abrasive wear” of 
both the soft UHMWPE and the hard surface of the 
femoral head (metal or ceramic)[29]. The relationship 
between the hardness of the third-body débris and 
the hardness of the bearing surfaces is the major 
determinant of the predisposition to abrasive wear[29].
Detailed cytological examination of the lytic tissue 
demonstrated that 70% to 90% of the debris load 
is constituted of polyethylene[4,30]. These particles 
have predominantly a spheroid shape and a size 
inferior to 1 µm (> 90%) with a mean size of 0.5 
µm[4,30]. According to the type of prosthesis implanted, 
other sorts of particles may be detected in the peri-
prosthetic membrane: polymethylmethacrylate, Co, 
Ti and ceramic. Silicates and stainless steel debris 
may also be seen but in a small amount since they 
are most likely contaminants from surgical tools or 
manufacturing process[4]. It is well admitted that the 
peri-prosthetic osteolysis does not ensue from the 
hostile effect of a single type of debris, but rather it 
is the cumulation of multiple physical, chemical and 
biologic factors. 
The bio-reactivity of wear particles depends 
on 2 major elements: (1) Particle characteristics 
(size, concentration and composition); and (2) Host 
characteristics (genetic variation dictating the immune 
system reactivity)[4,8,30]. Higher doses and smaller sizes 
induce more pertinent host response; this response 
also differs with the particle type where for example, 
Ti débris are more potent than PE particles of similar 
sizes[4]. Little agreement exists on what type of 
biomaterial debris is more bio-reactive, but there is a 
growing consensus that metallic debris is more pro-
inflammatory in vivo than polymer debris, despite 
contradictory statement reported by some authors[10].
Low doses of particles (Co-Cr, Ti and UHMWPE) 
strikingly promote the proliferation of the bone marrow 
stromal cells while high doses, mainly of Co-Cr, lead 
to cell death probably by reaching a toxic level[18,21,31]. 
The amount of generated wear debris is very critical to 
the stimulation of biologic response. In general, hard-
on-soft bearings produce larger debris than hard-on-
hard bearings do, where the average size of metal 
and ceramic debris is approximately 0.05 µm[10]. The 
aspect ratio of the debris is also important: elongated 
particles (fibers) are more potent than round particles 
in triggering the inflammatory reaction[10]. In general, 
the intensity of local inflammation depends on several 
critical debris characteristics: chemical reactivity, 
aspect ratio and particle load (size and volume)[10]. 
The critical size inciting the biologic response is one 
of controversial issues; in general, it is admitted, 
based on in vitro testing, that a particle should have 
a phagocytosable size to induce an inflammatory 
reaction (< 10 µm), with (0.24-7.2 µm) size range 
being the most pro-inflammatory.
Time of exposure is also an important factor 
contributing to osteolysis[5,31]. In addition, debris bio-
reactivity can be determined by the surface charge, 
energy and roughness as well as the aspect ratio 
(particle shape), and the composition and nature of the 
absorbed proteins[4,30]. Despite that particle features 
are considered to be the main factors controlling the 
induced biologic reaction, other factors also influence 
the onset and magnitude of this reaction. 
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Many radio-stereometric clinical and experimental 
studies have shown that mechanical instability of the 
implants is fundamental to induce the inflammatory 
reaction, where various amounts of different particles 
were shown to play a secondary role in osteolysis[8,32,33]; 
in contrary, particles seem to mainly inhibit bone 
formation around unstable implants more than induce 
osteolysis. Peri-prosthetic osteolysis could be the 
resultant of synergy between particulate debris and 
mechanical instability at the bone implant interface. 
Motion can lead to fibrous tissue formation that 
secrete different inflammatory mediators stimulating 
osteoclasts or can stimulate the extracellular matrix 
resulting in PGE2 and other cytokines release[32]. 
Therefore, primary implant fixation or instability 
portend subsequent clinical failure, result of loosening. 
Also interface mechanical stability, reflected by bone 
ingrowth, offers a sealing effect preventing the passage 
of PE debris from and to the effective joint space.
Interestingly, also the local fluid pressure in the 
fibrous membrane surrounding loose implants could 
be responsible of osteocytes apoptosis more than 
osteoclast activation; a fact that can be supported by 
the physiopathology of arthrosis-induced subchondral 
cysts and vascular aneurysms-induced bone erosion[33].
While a consensus about pro-inflammatory para-
meters, like particle load, has been established, the 
host reaction variability is still an area of darkness. 
As stated by Harris[9], many patients with extensive 
amounts of PE debris may not develop peri-prosthetic 
osteolysis. Distinct cellular response to prosthetic 
debris of loosened elbow arthroplasties has been 
demonstrated between patients with and without 
rheumatoid arthritis[13]. This different biologic reaction 
was not related to the amount or type of the prosthetic 
debris but was alleviated by anti-TNF therapy.
Hence, individual difference in macrophage sensitivity 
and/or osteoclast/osteoblast reaction, reflecting intrinsic 
variability in the immuno-regulation, is probably the 
most important underlying etiology of the debris-
induced hostile biologic reaction. Future investigations 
are warranted to determine whether individual genetic 
variances is the “maestro” of the inflammatory cascade.
The particle-induced chronic granulomatous inflam-
mation can be of 2 types: non-immune and immune[8]. 
Non-immune inflammation is a nonspecific reaction 
stimulating mainly the innate immune system[5,8] where 
fibroblasts and macrophages are the prominent cell 
types with scarce lymphocytes; it is specially caused 
by ceramic and polymeric debris. Immune reactions 
are induced by excessive metallic ions and particulates 
that stimulate both the innate and adaptive immune 
system[5,8]. The immune granulomas are dominated by 
lymphocytes (B and T) that are widespread, interacting 
with specific epitopes where they may form the so-
called “peri-vascular cuffing”[5,8]. The innate immune 
system can be activated by the toll-like receptors on 
the cell-membrane (“Toll” is a German word meaning 
“great, formidable”), that are one subtype of the 
specific receptors identifying the “molecular motif”; 
or it can be activated by the inflammasomes which 
are oligomeric protein complexes. The inflammasome 
complexes contain several types of proteins: caspase-1, 
NALP, PYCARD and sometimes caspase-5; its exact 
composition changes according to the activator that 
lead to its assembly. The inflammasome, especially 
activated by the metal particles[23], maturate the pro-
inflammatory factors IL-1 and IL-18 by cleaving their 
inactive domains once the inflammatory caspase-1 
cascade is stimulated[8]. The metallic ions-induced 
immune reaction has a spectrum of physiopathology 
ranging from benign fibrosis to severe type Ⅳ T 
lymphocytes-mediated hypersensitivity reaction leading 
in some cases to painful pseudo-tumors[8,23,30].
The inflammatory cascade generated once the 
prosthetic debris activate the cell, is an extremely 
complex process that is still not fully elucidated. Many 
older and recent studies have demonstrated the 
release of different families of inflammatory factors 
by several cell types of the peri-prosthetic tissue in 
reaction to all prosthetic debris. Goldring et al[34] were 
the first to state that the bone-implant interface in 
loose THA is composed of synovial-like membrane 
made of inflammatory cells producing PGE2 and 
collagenase.
The key cytokines, released by the inflammatory 
cells and responsible of bone resorption mainly 
include: IL-1, IL-6, IL-8, IL-10, IL-11 and TNF-α[4,8,26]. 
Also many other different factors are involved in this 
intricate reaction like prostaglandins (mainly PGE2)[4,8], 
growth factors (PDGF-α and TGF-β)[26], reactive 
oxygen intermediates (peroxide and nitric oxide)[8,24] 
and lysosomal enzymes (MMPs collagenase and 
stromelysin)[4] that are involved in the catabolism and 
reorganization of the organic extra-cellular bone matrix. 
Pap et al[35] reported that the fibroblasts and osteoclasts 
of the synovial-like peri-prosthetic tissue exhibit 
increased expression of several metalloproteinases 
(MMPs), like MMP-1, MMP-2, MMP-3, MMP-9 and 
MMP-13 contributing to matrix degradation.
The inflammatory response may be material-
dependent where a certain type of cytokine is more 
released in response to a specific particle, ex: IL-1 
predominates the stainless steel-induced reaction 
and PGE2 and IL-6 predominate the titanium-induced 
reaction[26].
TNF-α is an essential and extremely potent 
inflammatory mediator of the particle-induced bone 
resorption[36]. Merkel et al[36] showed, in an animal 
model study, that TNF-α is a crucial osteoclastogenic 
agent where “mice failing to express both the p55 
and p75 TNF receptors were protected from the 
profound bone resorption induced by the polymethyl-
methacrylate particles”. This information has a valuable 
clinical implication, where TNF receptors blockage can 
prevent wear particle-induced osteolysis.
In the presence of TNF-α and M-CSF, macrophages 
isolated from the peri-prosthetic tissue may differentiate 
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to osteoclasts in vitro, expressing vitronectin receptor 
and tartrate-resistant acid phosphatase (TRAP)[26]. TRAP, 
also known as acid phosphatase 5, is a glycosylated 
monomeric metallo-enzyme normally highly expressed 
by activated macrophages, osteoblasts and neurons.
Macrophage interaction with wear debris is constantly 
the chief phenomenon initiating the complex adverse 
local tissue reaction (ALTR) that lead to osteolysis and 
subsequent aseptic loosening. Among the numerous 
potent inflammatory mediators released, nitric oxide 
(NO) is copiously produced by the macrophages in a 
type- and dose-dependent manner of the challenging 
particles[26,37]. NO production is mainly stimulated by 
Ti-alloy particles followed by PMMA particles. The role 
of NO in the wear-induced adverse biologic reaction is 
not fully elucidated, since few studies investigated this 
chemical mediator. But it seems that it may play a role 
in the stimulation of PGE2 release and the inhibition of 
DNA synthesis[37].
Endotoxin adherence to the wear particles may 
play a primordial role in increasing the release of 
inflammatory cytokines in the peri-prosthetic tissue. 
This fact was demonstrated in vitro by several studies, 
but also was refuted by others[38-42]. Endotoxins, a term 
used nowadays as synonym for lipopolysaccharides, 
are large molecules found on the outer membrane of 
Gram negative bacteria. They are released only after 
complete destruction of the bacterial cell wall, hence 
eliciting a potent immune response. Their role in wear-
induced osteolysis is still controversial and needs to be 
more clarified in the future.
Recently, RANKL and osteoprotegerin (OPG) have 
been shown to play a major role in the initiation and 
progression of osteolytic lesions[4,8]. RANKL is an 
osteoblast receptor which activates osteoclasts by 
binding their surface receptor (Receptor Activator of 
NF-κB, also known as TRANCE Receptor) “RANK”. It 
is, like osteoprotegerin, a member of the TNF cytokine 
superfamily. The RANK pathway is the chief regulator 
of bone turnover (osteolysis) whereas osteoprotegerin 
is the antagonist of this pathway. Based on many 
animal model studies, RANK/RANKL/OPG pathway 
is now considered crucial for the occurrence of 
osteolysis[14]. The released inflammatory factors can act 
in a paracrine and autocrine manner[8], up-regulating 
osteoclast differentiation and maturation and sometimes 
reciprocally regulating their synthesis (like IL-1 and 
PGE2)[4].
Normal bone turnover rely on a balanced bone 
formation and bone resorption which are adjusted in 
harmony with the homeostatic and electrolytic condition 
of the organism. Many clinical studies and animal models 
demonstrated that the particle-induced inflammatory 
cascade not only up-regulate osteoclast function but 
also down-regulate the osteoblast and osteo-progenitor 
cells function[8,16,26,43], resulting in an unopposed bone 
resorption. In particular, several studies focused of 
the adverse effect of Ti particles stating that these 
particles suppress the gene expression and the proteo-
synthesis of collagen type Ⅰ and bone sialoprotein, alter 
the adhesive behavior of osteoblasts and trigger their 
apoptosis[26]. Similar sizes of Ti particles and ZrO2 have 
different effect on the osteoblastic gene expression: 
chronic Ti debris exposure, which can be secondary to 
mechanical instability of the implant, compromise “human 
MSC differentiation into functional osteoblasts”[26].
Mesenchymal stem cell apoptosis is induced by 
an increased level of the tumor suppressor proteins, 
p53 and p73. P53 (also known as p53 up-regulated 
modulator of apoptosis) may trigger cell death through 
several long and complex pathways, one of them 
starts by inhibition of the anti-apoptotic Bcl-2 family 
proteins, then activation of mitochondrial dysfunction, 
leading to the release of apoptogenic proteins from the 
mitochondrial membrane, like second mitochondria-
derived activator of caspases, apoptosis-inducing factor 
and cytochrome C[26]. P53 can lead to cell apoptosis 
through activation of death domain by soluble TNF 
cytokine receptors, like TNF-α and TNF-related 
apoptosis inducing ligand.
In other words, the osteogenetic function of 
osteoblasts is inhibited at the price of osteoclasto-
genesis which is regulated by mediators released by 
the peri-prosthetic osteoblasts themselves[43]. Hence, 
peri-prosthetic osteolysis is the resultant of 2 vectors: 
increased bone resorption by the inflammatory 
cytokines and the shifted osteoblast function, as 
well as decreased bone formation by the inhibited 
osteoblasts/osteoprogenitor stem cells.
The extent of the inflammatory reaction could 
be not locally confined to the prosthetic joint where 
debris is generated. Biomaterials debris (mainly PE 
and metallic) can be detected remotely from the 
affect joint, in the blood, urine, bone marrow, even in 
the liver, spleen, kidney, iliac and para-aortic lymph 
nodes, hair and nails[20,26]. The systemic immune 
reaction depends primarily on the macrophages 
chemotactic-function[8,24,44]. After stimulation of local 
peri-prosthetic cells, peripheral macrophages are 
recruited exacerbating the osteoclasto-genesis and 
subsequently peri-prosthetic bone resorption. Foreign 
bodies’ particles can be transported to distant cells of 
the reticulo-endothelial system via the peri-vascular 
lymphatic vessels; a fact that is supported by the 
presence of particle-collecting macrophages in the 
direct vicinity of blood vessels[19,20]. The extent of the 
distant transportation of wear debris depends on the 
amount produced as well as the capacity of the peri-
articular capsule to transport them[19]. It is assumed 
that systemic dissemination (mainly of metal particles) 
occurs when the ability of local cells to store foreign 
bodies is bypassed.
PROSTHETIC DEBRIS SPECIFICITY
The materials currently available for all prosthetic 
interface couples were present since more than 40 
years but recently, with the advances of metallurgy 
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processing and tribology knowledge, the manu-
facturing of these materials has been refined in order 
to decrease the volumetric wear associated with the 
traditional surfaces[30]. The new alternative couples 
nowadays available consist of the metal-on-highly 
cross-linked polyethylene and hard-on-hard bearing 
couples. All these new bearings require a meticulous 
surgical technique, specifically an excellent acetabular 
positioning in order to avoid the early complications 
that have been reported: squeaking, chipping or 
breakage, edge loading and impingement wear (stripe 
wear) associated with ceramic-on-ceramic couples[8], 
fracture or rim cracking of the highly cross-linked 
polyethylene liner and runaway wear and immune 
system-related complications (hypersensitivity and 
pseudo-tumors) associated with metal-on-metal 
couples.
Polyethylene debris 
Polyethylene was part of the historical MOP Charnley 
prosthesis. Even currently, the greatest majority of 
implemented THA consist of hard-on-soft couples 
(metal-on-polyethylene or ceramic-on-polyethylene), 
yet using the newest UHMWPE[7].
Polyethylene debris is considered the main culprit in 
inciting a hostile biologic response leading to osteolysis 
and aseptic loosening[4,7,15,20,29,30,45,46]. PE debris can 
transform appositional bone growth around well-fixed 
implants to chronic inflammatory tissue with abundant 
foreign body giant cells[16]. This fact resulted in growing 
interest in hard-on-hard bearings which have lower 
friction and wear rates, hence, theoretically, decreased 
incidence of aseptic loosening.
The wear rate for a “Charnley type” prosthesis 
couple is in average 0.1 mm/year, thus 1 mm/10 
years[6], where the generated debris have a size range 
of 0.5 to 5 µm, rarely increasing to 100 µm[15,19]. More 
than 90% of PE debris is smaller than 1μm with a mean 
size of 0.53 ± 0.3 µm[4,8,10,14,47]. This predominantly tiny 
size led originally to underestimation of the particles 
number contained in the peri-prosthetic membrane, 
until new identification methods came up (electron 
microscopy, proteolytic enzymes use and density-
gradient centrifugation)[14]. Kubo et al[48] showed that 
PE particles of 11 µm size are more biologically potent 
than larger PE particles; moreover, they showed that 
the particle’s material composition is more strongly 
related to the histiocytes reaction than the particle size 
and load.
In a review of PE and metal debris features, Doorn et 
al[47] reported that “approximately 500 billion particles 
can be produced per year, for a total amount of trillions 
of particles during the lifetime of a prosthesis”. 
PE debris is colorless and can have different shapes 
(flakes, needles, spears): the larger ones have the 
shape of splinters or plates and the smaller, that of 
granules or elongated platelets[19,47]. Since the majority 
(> 90%) of the PE particles is smaller than 1 µm, the 
spheroid shape is predominant[4,8]. The size could be 
related to the specific wear mode: smaller particles 
are generated when the PE surface is rubbing against 
bone cement or metals[47]. Polyethylene particles are 
immunologically inert and are not toxic[47].
Willert et al[19] noted that, unlike metallic debris, 
PE debris do not cause necrosis or fibrin exudation 
of the capsular tissue; but they do produce, as metal 
products, a marked fibrosis where a meshwork of 
differentiated collagen fibers form around the foreign 
body giant cells and phagocytes. According to these 
authors, this extensive fibrosis is not directly correlated 
to the embedded PE particles. Plastic particles may 
travel away from the involved joint occupying the peri-
vascular space[19].
Wear property of conventional PE can be markedly 
improved by cross-linking of ultrahigh molecular 
weight PE, either with radiation or with chemical 
means[49]. Five Mrad gamma radiation treatment 
lead to 85% improvement of wear resistance of the 
polyethylene. The improved wear characteristics of 
UHMWPE were proved in clinical studies as well as 
in laboratory testing using hip joint simulators. In a 
laboratory study where crossing-path motion was 
applied to hip simulator, McKellop et al[49] tested the 
wear resistance of crosslinked PE against extremely 
damaged femoral ball, trying to simulate extreme in 
vivo femoral head scratch by third-body abrasion. 
Laboratory crossing-path motion simulates more 
accurately hip joint in vivo than linear motion that 
could show an erroneous increased wear rate of cross-
linked PE[50]. They demonstrated that cross-linked PE, 
with or without accelerated aging, still exhibit better 
wear rate than conventional PE even against harshly 
damaged femoral head[49].
Despite that highly cross-linked polyethylene 
debris is smaller than conventional PE debris with a 
critical size range of 0.2 to 0.8 µm[7], they are more 
bio-reactive; however their decreased volumetric 
wear prevails over their increased biologic reaction 
triggering[30]. It is of utmost importance to notice that 
it is not the wear volume that determines the biologic 
response but mainly the dose and the smaller size of 
generated debris[7].
Metallic debris 
MOM couple was the first bearing used ever in the 
literature, first by Wiles, as early as 1938[20] then 
by McKee in 1940’s. Initially, higher revision rate 
was reported with McKee-Farrar prosthesis than the 
Charnley low friction arthroplasty. Despite the stated 
imperfection of the initial design (equatorial contact 
produce higher frictional torque and wear than polar 
contact), recent studies have shown good to excellent 
survival of McKee-Farrar prosthesis[6,15]. 
MOM bearings had enormously regained interest 
recently based on their main advantage over MOP 
bearings, which is a smaller volumetric wear by 
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more than an order of magnitude (10-40 times less 
wear for MOM than MOP). Even UHMWPE failed 
to eliminate the problem of osteolysis and aseptic 
loosening[20,23,29,30,47,51-53]. In one study, Willert et al[20] 
reported 39-fold higher wear rate for UHMWPE than 
MOM bearings. As it was once supposed that eliminating 
cement from THA could address the problem of aseptic 
loosening, exclusion of polyethylene liners by using 
MOM bearing was proposed as conceivable solution for 
osteolysis[47]. Second-generation MOM couples were 
introduced in the 1990’s to eliminate polyethylene-
induced osteolysis[12,13]. Commercially available Co-
Cr alloys have either low-carbide content (< 0.07%) 
or high-carbide content (> 0.2%)[12]. Carbide content 
affects the volumetric wear rate of CoCr alloys but not 
the particle size or morphologic features of the debris; 
high-carbide alloys have a wear rate of 2 to 5 µm/year 
whereas low-carbide alloys show a wear rate of 7.6 
µm[12]. Low-carbide content MOM alloys are associated 
with more prominent immunologic adverse response 
where in one clinical study[12], extensive necrosis was 
present in 90% of the interface membrane surrounding 
failed MOM along with higher intensity of diffuse peri-
vascular lymphocytic infiltration.
Although PE particles are considered the main 
etiology of peri-prosthetic osteolysis, metallic debris 
have been accused to cause ALTR leading to osteolysis, 
especially the Ti-alloy implants (Ti-6Al-4 V) more than 
Co-Cr alloy or stainless steel implants[12,13,26,47,54]. ALTR 
may cause intra-articular joint effusion characterized by 
sterile, watery, yellowish or grayish, hazy (tissue debris 
in suspension), basic (elevated pH) fluid with low cell 
count (lymphocytes)[54]. In fact, the metal-induced 
ALTR encompasses a spectrum of histo-pathologic 
changes including pure metallosis, aseptic lymphocyte-
dominated vasculitis-associated lesion (ALVAL) 
(detailed later in this paragraph) and granulomatous 
inflammation; ALVAL represents the precursor of 
lymphoid neogenesis[55]. 
The incidence of aseptic loosening leading to early 
failure of (MOM) TJA was recently estimated to be 
4% to 5%, 6 to 7 years after implantation[10]. Metal 
products can be released from any part of the implant 
and by different mechanisms: wear, corrosion, stress, 
fretting and fatigue[56].
On the other hand, the generated metallic particles 
are smaller in size, of nanometer-order ranging from 
30 nm to 200 µm (with majority of < 50 nm)[10,23,30,51]. 
Willert et al[19,20] reported a range size of 0.5 to 5 µm 
for the metallic wear debris; likewise other authors 
reported only micron-order size (0.1-1 µm) for the 
metallic debris with no clear difference between 
different metal alloys[47]. So despite the decreased 
volumetric wear associated with MOM couples, the 
resultant surface/area mass is extensive since the 
tiny particle sizes of metallic débris are produced at 
higher rate than MOP bearings[23,30,53]. Nevertheless, 
macrophage activation and cytokine release can 
be induced only by high volumetric concentrations 
of Co-Cr wear particles[51]. If not phagocytosed by 
macrophages, metallic products can be disseminated 
to the reticulo-endothelial system via the lymphatic 
vessels[53]. 
Wear of the metallic articulating surfaces can be 
manifested macroscopically by delicate scratches (that 
are sometimes more located in the weight-bearing 
areas) or polishing of various locations and sizes[20]. 
However scratches of the prosthesis articulating 
surfaces are not the primary source of metallic debris, 
where the anchoring surfaces of the implant represent 
the more powerful source of debris exhibiting polishing 
that is secondary to debonding of the implant and its 
subsequent movement against the bone cements[20]. 
Only in the circumstance of impingement between 
the cup rim and the stem neck, metallic wear debris 
emanates mainly from the articulating surfaces of the 
prosthesis[20].
Moreover, MOM bearings can undergo corrosion 
(electro-chemical dissociation) releasing free metallic 
products that can interact with the surrounding cells of 
the host tissue and the local body fluids forming complex 
organic and inorganic metallic products[20,23,30,51]. The 
process underlying the generation of metal products is ill-
defined[30]. The wear debris derived from MOM implants 
can have one of 2 forms[23]: metal particulates or free 
metal ions like Cr3+, Cr6+ and Co2+. The predominant type 
of metallic wear particles is nanometer-sized chromium 
oxide (Cr2O3); but chromium particles are not the main 
offender in triggering the biological cascade[20,25]. In 
decreasing order after chromium particles, cobalt, nickel 
and molybdenum debris can be produced[19,20]. But also 
other soluble metal ions can be formed based on the 
type of the implanted alloy, like: aluminum, vanadium 
and titanium[10].
One clinical study found that aseptic loosening of 
uncemented MOM hip prosthesis result in a significant 
increase in cobalt serum level but not chromium[56]. 
The authors reported a 2.8 relative risk of implant 
loosening for a serum cobalt concentration greater 
than 9 nmol/L. 
Metallic particles have an amorphous, irregular 
shape (flakes or needles) with sharp edges and a 
black color staining black the inner layer of the joint 
capsule[19,20,47]. Submicron sized metal debris procure a 
blue color to the cellular cytoplasm[47].
The in vivo number of metal particles released 
per year is estimated to range from 6 × 1012 to 250 
× 1012 particles[23]. Basic processes of the adverse 
biologic responses apply also to metal products. Metal 
debris up-regulate the transcription factor NF-κB and 
activate the monocyte/macrophage lineage releasing 
inflammatory cytokines like IL-1β, IL-6, IL-8 and TNF-α. 
However, metal debris has the specificity of activating 
the inflammasome danger-signaling in macrophages; 
this inflammasome activation lead to the maturation of 
IL-1β and IL-8[10,23]. Once the inflammatory mediators 
are released, osteoblast inhibition and osteoclast 
activation ensue, as previously mentioned in detail.
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Systemic dissemination of the metallic debris via 
the lymphatic circulation: The cumulative effects of 
the biological behavior of the metallic debris and their 
nanometer size range may result in a systemic increase 
of ions levels, mainly cobalt and chromium serum, 
urine and synovial fluid concentrations[15,23,30,51,53,57]. 
Likewise patients with bilateral large-head MOM have 
higher serum metal ions concentrations compared 
to the patients with unilateral MOM[23]. To diagnose 
systemic release of metal ions, normal human serum 
concentrations of the mostly inserted metals should be 
recognized: [Cr] = 0.15 ng/mL, [Co] = 0.1-0.2 ng/mL, 
[Al] = 1-10 ng/mL, [Ti] less than 4.1 ng/mL and [V] 
less than 0.01 ng/mL.
In one study, there was up to 6- to 7-fold increase 
in the serologic concentration of cobalt and chromium 
with small increase in molybdenum level[58]. Another 
study comparing 4 groups of patients (healthy controls, 
patients with O.A. without TJA, patients with well-
functioning MOP and patients with well-functioning 
MOM THA), has shown a 13-fold increase in Co and 
58-fold increase in Cr concentrations[31]. Several studies 
reported similar Co and Cr levels in the serum of 
patients with stable MOM prosthesis and those who do 
not have any implanted prosthesis[56]. To be noted that 
there is imperfect correlation between the serologic ion 
levels, wear rate and incidence of ALTR[54].
The systemic release of metallic ions is a major 
concern even though acute and forthright toxicity 
is exceedingly rare, where the incidence of patients 
necessitating revision for probable hypersensitivity 
to otherwise well-performing MOM bearings is very 
low[30]. Even well-performing MOM arthroplasties have 
shown 3 to 5 times increase in Co and Cr levels[13]. 
Renal failure can potentiate the detrimental effect of 
the metallic debris, highlighting the problem of chronic 
toxicity which is still uncertain nowadays[30,53]. However, 
it is admitted that the local concentration of metallic 
debris in the synovial fluid seldom exceed the threshold 
identified as toxic in vitro or dangerous in occupational 
medicine[53]. Willert et al[20] reported a low metal 
content in the peri-prosthetic tissue of MOM bearings 
(metal debris representing 0.1% of this tissue), but 
Huo et al[46] reported higher metal and Ba content for 
loosened implants. The in vivo relationship between 
intracellular debris content and disease development is 
not fully clear, but toxicity and carcinogenicity of metallic 
debris have been demonstrated in animal experimental 
models and in in vitro tissue cultures, as well as in 
clinical studies[57]. Numerous neoplastic tumors have 
been reported in tissue contiguous to metal prosthesis: 
lymphomas, malignant fibrous histiocytomas, sarcomas, 
and haemangio-endothelioma[57]. Likewise, increased 
incidence of lymphoma and leukemia has been reported 
after THA in 2 epidemiologic studies[57] but was refuted by 
other reports[10]. Increased levels of chromium can lead 
to carcinogenesis, hypersensitivity and nephropathy[57]. 
Excessive amounts of cobalt can cause hypothyroidism, 
polycythemia, neoplasia and cardiomyopathies[10]; 
although Co-induced cardiomyopathy is a theoretical 
concern, several reports stated that cobalt-containing 
beer could be the possible culprit of lethal cardiac 
myopathies[59,60]. Vanadium as well, has been associated 
with renal and cardiac disorder, hypertension and bipolar 
psychosis[10]. Nickel and aluminum carcinogenicity to the 
lung and bladder tissue was reported in industrially exposed 
workers; nickel is also associated with hypersensitivity and 
eczematous dermatitis[10,57]. Similarly, increased aluminum 
level was shown to be a possible etiology of senile 
dementia, encephalopathy and diminished bone mineral 
density.
Despite all these literature reports, no clear correlation 
has been established between metal release from 
implants and neoplastic, toxic or metabolic diseases. 
Whenever wear debris are copiously generated, they 
will exceed the capacity of the local tissue to eliminate 
them, leading to accumulation and consequently 
systemic dissemination of these metallic particles 
which can be, theoretically, harmful to any reached 
organ. Besides, it has been shown that cobalt chrome 
alloy-containing prosthesis (whether MOM or MOP) can 
cause chromosomal aberrations, like translocations 
(1.5-fold) and aneuploidy (2 to 4-fold) which clinical 
significance is still unclear[23,30,51,59]. 
Metal products have a specific biological behavior 
consisting of triggering a significant and complex immune 
response involving B and T lymphocytes; this can result 
in abnormal masses (fibrosis or hystiocytosis), bursa 
hypertrophy or tissue necrosis[23,30]. A shift in the CD4+/
CD8+ circulating lymphocyte ratio was demonstrated 
in patients with well-functioning implants[5]. It is still 
unclear if this immune response is the resultant of 
patient hypersensitivity or increased metal products 
concentration in the peripheral blood. Recently, Lohmann 
et al[61] stated that the type of tissue reaction in failed 
MOM arthroplasties may be predicted by the peri-
prosthetic tissue metal content and not by the serum 
metal content. They demonstrated that tissues with 
higher metal content (222.2 ± 52.9 µg/g) exhibited a 
predominantly lymphocytic response and those with 
lower metal content (3.0 ± 0.9 µg/g) showed a non-
specific macrophage-mediated granulomatous response. 
A long-standing problematic issue was and is 
still to be “metal allergy” that is irrefutably a real 
clinical fact but with uncertain prevalence and clinical 
repercussion[30,31,51]. Evans et al[62] were the first to 
report, in 1974, that metal sensitivity is a cause for 
bone necrosis and prosthesis loosening where metallic 
particles released from MOM bearings may obliterate 
the blood vessels irrigating the peri-prosthetic bone 
leading to its necrosis. Hypersensitivity can be 
manifested clinically by urticaria, dermatitis, and 
vasculitis.
The main metal sensitizers embrace, in order of 
potency: nickel (Ni), cobalt (Co) and chromium (Cr); 
Titanium (Ti), vanadium (V) and tantalum (Ta) are 
exceedingly rare cause of immune hypersensitivity[31]. 
Nickel is the most potent and most common metal 
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sensitizer where 14% of the general population has 
dermal sensitivity to Ni[10]. Dermal metal sensitivity 
has an estimated prevalence of 10% among the 
general population, 25% among patients with well-
functioning TJA and 60% among patients with poorly-
performing TJA[10,31]. In case of early MOM failure, the 
prevalence of metal sensitivity is estimated to be six-
times that of the general population[10].
Metal-induced allergic response is similar to T 
Lymphocytes-mediated delayed-type hypersensitivity 
response (type Ⅳ); in this response, T lymphocytes are 
activated by a primary then secondary stimulus, which 
are respectively metal ions (or metal particulates-
proteins complexes) and danger-associated molecular 
patterns (DAMPs). DAMPs can be endogenous alarmins 
released from damaged cells (such as monosodium 
urate crystals) or exogenous microbial pathogen-
associated molecular patterns that can incite innate 
immunity through Toll-like receptors (TLR) activation. 
This will lead to a complex interaction between the 
antigen-presenting dendritic cells that release TNF-α 
and IL-1 and T lymphocytes that release interferon-γ. 
A recent in vitro study has showed that “Toll-like 
receptor 4” on the macrophage surface are crucial in 
mediating the pro-inflammatory immune response to 
cobalt-alloy particles[23]. TLRs are cell surface receptors 
expressed in neutrophils, B-cells, dendritic cells and 
macrophages; More than 10 human TLRs are identified 
where TLR4 is one of the best described TLR. Particle-
challenged human monocytes, beside contributing to 
other important aspects of the inflammatory response, 
up-regulated IL-1β, TNF-α and IL-8[23]; and this rise in 
cytokine release was proportional to particle:cell ratio 
and was induced either by particle phagocytosis or by 
extra-cellular stimulation of TLR4. Blocking TLR4 by 
antibodies before exposure to Co debris caused 46% 
inhibition of IL-8 mRNA expression and 72% decrease 
in IL-8 protein synthesis in 24 h[23].
Despite that metal-induced allergic reaction is 
considered idiosyncratic, some clinical studies could 
demonstrate dose-dependent reaction intensity 
with proportional relationship between lymphocyte 
reactivity levels and serum-metal levels[23,31]. But no 
clear causativeness could be established between 
metal-induced lymphocyte reactivity and poor metallic 
implant performance[31].
Latterly, MOM bearings showed a unique histologic 
reaction of prominent perivascular and/or diffuse 
intramural lymphocytic infiltration which is evocative of 
a cell-mediated delayed-type hypersensitivity response. 
Willert et al[63] termed this response to failed second-
generation MOM bearings, ALVAL or “lymphocyte-
dominated immunological answer” (LYDIA) which 
is actually an area of active investigation. ALVAL or 
LYDIA is an histologic reaction consisting of “diffuse 
and peri-vascular infiltrate of T- and B-lymphocytes 
and plasma cells, high endothelial venules, localized 
bleeding, massive fibrin exudation, accumulation of 
macrophages with drop-like inclusions and infiltrates 
of eosinophils and necrosis”[63]. The histo-chemical 
examination of the macrophages inclusions did not 
show the phagocytosis of implant-debris but more 
likely phagocytosis of organic material. The majority 
of the examined tissue “contained small amounts of 
histologically visible metal wear particles”, suggesting 
no correlation between the observed immunologic 
reaction and the particle dose confined in the tissue[63].
Clinically, ALVAL can be manifested by persistent 
or recurrent pain, soon after primary THA, along with 
prominent hip effusion, necessitating revision surgery 
even for well-fixed implants[63]. 
Based on recent clinical studies, a correlation was 
established between positive patch test or histologic 
evidence of ALVAL, and early osteolysis in patients with 
MOM bearings. Definitely, a poorly-functioning MOM 
prosthesis produce higher wear rate and subsequently 
established osteolysis that leads to implant loosening.
Patients with “ALVAL” may experience pain or 
may develop pseudo-tumors[20,23,64] that are one of 
the serious consequences of metal debris. Pseudo-
tumors, which mechanism of formation is unclear, are 
complex lesions of lymphocytes, fibroblasts, multi-
nucleated cells (with metallic debris inclusions)[20] 
and granulocytes[23] with significantly high IL-8 
(approximately 200-fold higher than IL-1β and TNF-α 
levels released by the challenged macrophages)[23]. 
IL-8 is characterized by strong chemotactic effect that 
may instigate and maintain cellular infiltration leading 
to pseudo-tumor formation. Pandit et al[64] were the 
first, in 2008, to describe abnormal soft-tissue mass 
around the hip using the term of “pseudotumors” 
because these masses are neither infective neither 
neoplastic. In their large series of hip resurfacings 
(1300 cases), they observed 12 cases of pseudotumors 
reporting an incidence of 1% at 5 years; they also 
stated that some cases were asymptomatic and were 
discovered incidentally, indicating that the incidence 
of this abnormal mass, which can be overlooked 
clinically, could be higher than initially estimated. The 
most common presentation of pseudotumors was 
hip discomfort, but also nerve palsy, spontaneous 
dislocation, rash and obvious palpable mass could 
occur[64]. To be noted that Boardman et al[65] reported, 
in 2006, a single case of benign psoas mass, secondary 
to MOM hip resurfacing, that resolved after conversion 
to conventional THR. Interestingly, a case report was 
recently published stating pseudo-tumor formation and 
metallosis in a modular hip hemiarthroplasty where 
the corrosion products arose from the non-articulating 
modular prosthetic junction[66]. 
Since host factors determining the reactivity 
to wear products are still ill-defined (where some 
patients develop marked reactivity after a short period 
of MOM implantation and others can tolerate great 
debris loads for long period)[31], and since the toxi-
cological implication of high metal ions are not fully 
elucidated[10,30], patients monitoring, in the circumstance 
of any clinical or radiographic doubt, with regular metal 
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ions measurements seems to be judicious[54]. 
In summary, MOM bearings use in arthroplasty 
had re-emerged recently after UHMWPE failed to 
prevent osteolysis. The wear rate of MOM determines 
the potential of these bearings to trigger the adverse 
biologic reactions; still to be determined in the future, 
what wear rate of modern MOM couples is considered 
safe, precluding the innumerable toxicity associated 
with metal products. This wear rate, that is by far 
less than that of plastic, can be further reduced with 
the use of better design (especially carbon-containing 
alloy and metal fabrication by forging rather than 
casting) and larger femoral head with improved radial 
clearance or perhaps with combination of different 
hard surfaces[12,15,51,52]. And even when metallic wear 
is histo-pathologically demonstrated, metal debris 
do not dominate the adverse histologic reaction[20]. 
Conformity between the prosthesis components is 
required, but at least a 0.15- to 0.20-mm clearance 
should exist between the ball and socket to allow 
fluid ingress[20]. Despite all the achieved advances in 
the manufacturing process, creating metallic material 
with excellent tribologic qualities (wear, friction and 
lubrication), metal hypersensitivity, toxicity and 
pseudo-tumors risks remain a dreaded issue which is 
still not fully controllable.
Ceramic debris
The French surgeon, Pierre BOUTIN, was the first to 
implement a COC total hip replacement[6]. Since then, 
COC couples had become an attractive, reliable and 
more durable alternative to traditional bearings of THA, 
especially with the design and material improvements 
accomplished with time (microstructure, density, 
mechanical strength and surface finish of ceramic 
materials). Despite their earlier use in Europe, alumina 
femoral heads were not available in the United States 
until the early 1980’s and Zirconia heads until 1989[15].
Ceramics are stable solid compounds of metals 
and nonmetals (like oxygen or other anions), with 
the 2 main ceramic materials, nowadays in clinical 
use, being alumina (Al2O3) and Zirconia (ZrO2)[15,67]. 
Ceramics gained interest because of their favorable 
characteristics of biochemical inertness, hardness 
(they resist scratching and maintain their polished 
finishing), wettability, high-strength, corrosion and 
wear resistance and thermodynamic stability[15,67,68]. 
Ceramics are considerably harder than both CoCr 
and Ti alloy tapers[15]. Resistance to abrasive wear is 
proportional to the hardness of the bearing surface; 
subsequently ceramic surfaces are more resistant to 
abrasive wear than metallic surfaces[29]. Laboratory 
testing had demonstrated that different kinds of wear 
debris can cause a visible abrasion of all metal surfaces 
(including nitrogen ion implanted Ti-6Al-4V) but not 
of ceramic surfaces which, in addition, produce less 
UHMWPE wear than metallic surfaces[29].
Ceramic compounds are extremely inert biologically 
and chemically because the reaction of their formation 
(where base metals, like aluminum, react with oxygen) 
is highly exothermic, setting these compounds in a 
very low energy state, hence precluding any further 
dissociation[67]. Unlike PE that are nonpolar and nonionic 
molecules, ceramic materials have an ionic structure 
making their surface hydrophilic; this allows the “polar” 
water-based fluids to spread over their surface reducing 
the intimate contact between PE and ceramic[15].
On the other hand, ceramic’s brittleness constitutes
a drawback which carries a dreaded risk of fracture 
which cause is, nowadays, attributed to a manu-
facturing defect[6,67]. The strongest zirconium oxide was 
introduced to reduce the risk of catastrophic failure 
(fracture) and to expand the available size range of 
ceramic components[15]. With the greater fracture 
toughness (approximately twice that of Al2O3) and 
higher strength of ZrO2, smaller heads and longer necks 
could be used but still without attaining the size range 
available with CoCr heads[15]. 
Ceramics have exceptional compression strength 
but poor bending strength making them unable to 
deform without breakage[68]. The fracture rate reported 
in the literature varied tremendously from 0% to 
13%. Among others, Hannouche et al[68] reported an 
extremely low fracture rate of 0.2% (13 components 
fracture out of 5500 implanted over a period of 25 
years). They recommended a meticulous surgical 
technique in the use of ceramic femoral head to 
preclude fracture and stated that this exceedingly rare 
complication can be overcome by the more common 
risk of wear and osteolysis associated with MOP or even 
MOM bearings. Interestingly, Heck et al[69] reported 
that the fracture rate of alumina ceramic is less than PE 
liner fracture (that represents the weakest link in THA) 
or metallic stem fracture. Recently, even lower fracture 
rate has been reported (0.004%)[70]. It is worth to note 
again that ceramic fracture can be effectively reduced 
by following a scrupulous surgical technique avoiding 
excessive abduction of the acetabular component and 
ensuring a concentric fit of the femoral head on the 
Morse taper. Before axial impaction, the femoral head 
should be rotated to guarantee its concentric seating 
on the trunion to avoid any gouging of the taper by 
the border of ceramic head[15]. Failure of the Morse 
taper can be catastrophic leading to fretting corrosion 
and severe metallosis with metallic embedding in the 
ceramic bearing surfaces[71].
The wear volume associated with ceramic bearings is 
considerably less than that of metallic bearings[6,30,31]. PE 
component in COP bearings exhibits a linear wear that 
is 5 to 10 fold lower than PE wear in MOP bearings[15]. 
Because they do not experience surface roughening with 
time as metal bearings do, ceramics reduce the long-
term UHMWPE wear, more than metals[72]. Likewise, COC 
wear rate is 10-times less than the lowest PE wear rate, 
being around 0.003 mm/year[15]. This decreased debris 
generation accounts for the reduced likelihood of adverse 
biologic reaction and osteolysis with ceramic bearings.
As previously mentioned, bulk form of ceramics is 
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inert, sparing the environmental oxidative deterioration[30]. 
On the other hand, once ceramic particles are produced, 
only in the setting of flawed or poorly functioning 
components, they induce a cellular response similar in 
intensity and quality to that triggered by the polymeric 
and metallic debris[15,30]. A recent study showed that, 
in contrast to failed MOP bearings, ceramic wear debris 
and osteolysis are the consequence rather than the 
cause of COC bearings failure[11]. It is true that the 
initial design and tribologic material of ceramics were 
responsible of wear generation and subsequent early 
failure. But at the present time, early failure of COC is 
deemed to be secondary to mechanical problems (initial 
malpositioning or instability) or infection. Hereafter, 
ceramic bearings are more sensitive to technical errors 
of implantations than other bearings.
Like metallic products, the ceramic wear debris 
is small in size, henceforth are produced in greater 
number, saturating the surface area of the host cells[15]. 
Some authors reported that ceramic particles size 
range from 0.13 to 7.2 µm with an average of 0.71 
µm[15]; But allegedly, ceramic particles size range is 
bimodal: nanometer-scale of magnitude for most of 
these particles and submicron- to micron-order for the 
remaining part with a mean size of 0.7 µm (as for the 
polyethylene debris)[30]. Once again, the main biologic 
factors that determine the cellular response remain 
to be the particle characteristics (shape, volume and 
size). But unlike metal products, different ceramic 
wear products (alumina or Zirconia) do not stimulate 
the adaptive immune system because they do not 
experience any corrosion.
Despite the fact that ceramics are considered 
biologically indolent, ceramics products bio-inertness 
has been questioned by some studies. Li et al[73] 
showed that alumina and hydroxyapatite have no 
cytotoxic effects to the in vitro cultured human 
fibroblasts challenged by different particle doses 
(1-500 µ/mL), while zirconia and tricalcium phosphate 
inhibited cell viability, where a concentration of about 
50 µg/mL decreased cell viability by 50%. Likewise, 
Lerouge et al[74] demonstrated, through an in vivo 
characterization of wear debris generated from COC 
THA, that ZrO2 and not Al2O3 particles, induce a 
histiocytic foreign-body reaction and are the major 
particles responsible of aseptic loosening associated 
with COC bearings. Alumina oxide particles were 
found in only 12% of the histologic sections analysis, 
whereas zirconium oxide debris were by far more 
numerous and were found in 76%; the third particle 
type retrieved being Ti alloy debris. In contrast to these 
studies, a more recent study showed that Al2O3 and 
ZrO2 do not alter the metabolism of arachidonic acid of 
synoviocytes cell membrane neither increase IL-1 and 
IL-6 release[75]. Synovial tissue contains two different 
cell types: Type A, macrophage-like synoviocytes and, 
type B, fibroblast-like synoviocytes. The latter are 
responsible for synovial hyperplasia and are involved 
in activating the cellular inflammatory reaction by 
releasing several kinds of inflammatory mediators. 
Both IL-1 and IL-6 are elevated in the synovial fluid 
of rheumatoid arthritis (RA) patients. Arachidonic acid 
metabolites [like (LTB4) leukotriene B4] play a major 
role in the pathogenesis of multiple inflammatory 
diseases like asthma, inflammatory bowel disease 
and RA. A recent in-vitro study suggested that 
biocompatibility of zirconia is greater than that of 
titanium[76]. Cultured macrophages challenged with 
both titanium or Zirconia particles expressed increased 
mRNA for TLRs 2, 3, 4 and 9, and their intracellular 
adaptors and pro-inflammatory cytokines. However, 
quantitative differences were evident where zirconia-
induced pro-inflammatory gene expression was lower 
than that provoked by titanium particles.
In summary, COC bearings have the great 
advantage, over other bearings, of decreased wear 
rate due to their hardness which resist scratching, 
making them more suitable for younger patients. 
Disadvantages of ceramics include their cost[70] and 
the limited range of neck size available because of 
the fracture risk. Fracture risk can be tremendously 
reduced by following a thorough surgical technique 
and by ensuring an excellent ceramic manufacturing 
with a quality is nondestructively pre-clinically tested. 
The increased cost of ceramics seems to be justified, 
especially in young patients, by the decreased wear 
rate of COP vs MOP, even with traditional PE[70]. 
Ceramic-on-polyethylene bearings exhibit a wear 
rate of 0.034 mm/year compared to 0.1 mm/year 
for metal-on-polyethylene bearings. Ceramic-on-
crosslinked PE couples display a wear rate of 0.019 
mm/year compared to 0.03 mm/year for metal-on-
crosslinked PE.
Polymethylmethacrylate debris
Cemented fixation of both components of THA was the 
initial fixation method proposed by Charnley[1,14]. In 
1989 at Boston, William Harris was the 1st to develop 
and implement a hybrid hip prosthesis with cementless 
press-fitted hemispherical metallic cup and cemented 
titanium femoral stem[6].
It is recommended nowadays not to use a cemented 
titanium stem because it can generate tremendous 
amount of Ti debris once loosened, and to use proximally 
or fully hydroxyapatite-coated cementless titanium 
stem[6]. Salvati et al[18] stated that the synovial fluid 
contain a significantly higher levels of metal debris 
with loosened cemented titanium stem (21-fold) than 
loosened cemented cobalt-chromium stem (7-fold).
The biologic response triggered by PE wear particles 
is almost similar to that induced by other types of 
particles. A majority of studies challenged inflammatory 
cells by different kinds of debris, including PMMA 
debris, and showed quit identical cellular reaction[21,44]. 
In fact, PMMA debris are not the sole foreign material 
found in the peri-prosthetic tissue; based on the type 
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of implanted prosthesis, other particles can be found 
(metal, plastic...). Hence, if one of these foreign 
particles triggers the inflammatory cascade, other 
particles types perpetuate this adverse reaction[19]. 
Willert et al[20] showed that cement-induced reaction 
more frequently outweighs metal-induced reaction; but 
different scenarios may also exist but less frequently.
Macrophages are always the primordial cell type 
involved in the adverse biologic response, secreting 
several inflammatory mediators mainly IL-1 and TNF-α. 
Likewise, PMMA debris recruit peripheral monocyte/
macrophages enhancing cell cluttering in the nidus of 
wear debris, the peri-prosthetic interface membrane[44].
If the cement mantle is macroscopically destroyed 
or disorganized, PMMA particles may be found within 
the capsular tissue[19]. Acrylic particles have a size range 
of 1-2 µm to several hundreds of microns and different 
shape organization: the smallest ones are dust-like 
granules and the largest are like pearls clusters or grapes 
bunch[19,20]. According to their size, PMMA particles can 
be or not phagocytosed and stored within inclusions in 
the foamy cytoplasm of macrophages[19]. As previously 
mentioned, foreign body giant cells predominate in 
cement-induced aseptic loosening, surrounding the non-
phagocytosable large cement fragments. Hence, fibrosis 
or hyalinization and necrosis of granulomas (formed 
by Histiocytes incorporating foreign materials) are less 
common with acrylic particles, as well as plasma cells 
and lymphocytes infiltration[19]. 
If the polymethylmethacrylate bone cement contains 
radio-opaque contrast media, ZrO2 or BaSO4, traces 
of these molecules can be detectable in macrophages 
(or less commonly in foreign body giant cell) inclusions 
reflecting the disintegration of the bone cement 
storage in the tissue. The BaSO4 or ZrO2 particles have 
an average size of 0.5 to 8 µm[20]. So disintegration of 
the bone cement can produce PMMA particles and/or 
ZrO2 or BaSO4 particles that, besides their direct effect, 
can cause a third-body wear once they reach the 
articulation compartment[20].
Aseptic loosening of cemented prosthesis can display 
one of 2 forms: extensive granulomatosis or non-
granulomatous aseptic loosening[77]. PMMA debris can 
elicit an immunologic-type adverse biologic reaction, 
a T-lymphocyte mediated hypersensitivity immune 
response[77]. The bone-cement interface membrane is 
infiltrated by monocytes-macrophages and multinucleated 
giant cells encumbered with cement particles. Whereas 
Santavirta et al[77] demonstrated a difference in the 
immune-pathologic response between granulomatous 
and non-granulomatous aseptic loosening, Gil-Albarova 
et al[78] showed no difference with increase of both 
total and activated CD2-positive T lymphocytes in 
both types of loosening. Likewise, Santavirta et al[77] 
considered these 2 forms of aseptic loosening as 2 
different conditions on the basis of the relative lack 
of fibroblasts in the peri-prosthetic membrane, with 
activated fibroblasts being the main cell constituent 
of non-granulomatous aseptic loosening. Gil-Albarova 
et al[78] stated that both histo-pathological patterns 
have a single systemic immune response and have no 
difference regarding lymphocytes subtypes (increase 
in B and T lymphocytes, mainly CD2, CD22 and CD25 
positive cells), patch test reactivity and lymphoblast 
transformation test induced by PMMA material[77]. 
FUTURE DIRECTIONS AND TREATMENT 
STRATEGIES 
One of the essential repercussions of advanced 
understanding of the problematical osteolysis process 
is the development of novel therapeutic modalities 
that may slow down or prevent disease progression. 
The pharmacotherapy may target any stage of the 
intricate inflammatory reaction to wear debris: anti-
inflammatory agents may be used to modulate the 
cytokines release, anti-osteolytic agents to disintegrate 
osteoclasts morphology, and antioxidants to demolish 
the free oxygen radicals produced by the activated 
macrophages. On the other hand, osteolysis may 
be prevented using osteogenic growth factors that 
play a critical role in bone formation, remodeling and 
reparation.
Based on the fact that cytokines constitute the major 
mediators of the debris-induced adverse response, anti-
inflammatory agents have been proposed to down-
regulate this reaction. Blaine et al[79] reported the 
modulatory effect of some pharmacologic agents, 
that alter the intracellular levels of cAMP, on cytokines 
production (IL-6 and TNF-α) by titanium-stimulated 
human peripheral blood monocytes[79]. Interestingly, 
active cAMP analogs (Dibutyryl cAMP) and prostaglandins 
(E1 and E2) enhanced IL-6 synthesis but inhibited 
TNF-α production. They showed also that some anti-
inflammatory products (indomethacin) may potentiate 
cytokine production (3 fold increase in TNF-α production). 
This finding implicate that one should understand the 
echelon of action of anti-inflammatory medication 
proposed to delay the disease process, and that the role 
of culprit cytokines should be stratified by potency weight, 
since the used agent may inhibit one inflammatory 
mediator at the price of enhancing other. Likewise, 
Schwarz et al[80] stated that periprosthetic osteolysis and 
inflammation can be controlled by anti-TNF-α therapy. 
In an exceptionally novel technique, Keeney et al[24] 
stated that the debris-induced inflammatory response 
can be modulated by mutant MCP-1 protein delivery 
from biodegradable layer-by-layer coatings on orthopedic 
implants. As previously mentioned, MCP-1 is one of 
the most potent cytokines involved in macrophages 
recruitment, whose receptors may be blocked using 
a decoy drug, such as 7nd, a mutant MCP-1 protein. 
Interestingly, Vallés et al[81] stated that simvastatin pre-
treatment of human osteoblastic cells down-regulated 
Ti particle-induced IL-6 gene expression at mRNA and 
protein levels. Statins, well-known hypo-lipidemiant 
185 March 18, 2015|Volume 6|Issue 2|WJO|www.wjgnet.com
Bitar D et al . Biological response to prosthetic debris
drugs, have anti-inflammatory, immune-modulatory and 
osteo-anabolic effects where they suppress osteoclastic 
bone resorption and support osteoblast-precursors 
recruitment enhancing proliferation, differentiation and 
mineralization of osteoblasts. Metal debris particularly up-
regulate IL-6 release by osteoblasts and peri-prosthetic 
membranous tissues. 
Bisphosphonates have been shown to be potent anti-
osteolytic agents that interfere with internal enzymatic cell 
system disrupting the osteoclast cytoskeleton, effectively 
used in the treatment of metabolic bone disease with 
prominent bone resorption, including osteoporosis, Paget’s
disease and metastatic hypercalcemia[82,83]. Several 
animal model studies demonstrated the inhibitory effect 
of bisphosphonates on particle-induced bone resorption. 
Horowitz et al[84] showed that disodium pamidronate 
is effective in reversing the bone resorption secondary 
to macrophage exposure to bone cement particles. 
Similarly, Shanbhag et al[85] reported that alendronate, 
which is integrated in the mineralizing matrix inhibiting 
osteoclastic activity, reduced debris-induced osteolysis 
(PE/Ti/Co-Cr) in a canine THA model. A recent meta-
analysis, including six randomized controlled trials, 
suggested that bisphosphonates are advantageous in 
preserving more peri-prosthetic bone mineral density 
than that in controls[86]. More recently, a clinical study 
showed that parenteral (intra-muscular) administration 
of neridronate, every fortnight for the first three months 
then every month for the remaining period of 1-year 
follow-up, reduced pain, improved function and halted 
the roentgenographic evolution of peri-prosthetic 
osteolysis, as well as amplified peri-prosthetic bone 
mineral density as confirmed by DEXA measurements[87]. 
Since reactive oxygen species (mainly produced 
by the phagocyte immune cell type) and reactive 
nitrogen species (a family of antimicrobial molecules 
derived from NO and superoxide) may mediate aseptic 
inflammation affecting directly periprosthetic osteolysis, 
antioxidants use is an attractive manner to modulate 
the disease process. Antioxidants, such as ascorbic 
acid[88], bioflavonoid pycnogenol[89], N-acetylcysteine[90], 
pyrrolidinedithiocarbamic acid[90], are potent free radical 
scavengers down regulating the phagocytic immune 
response. Bioflavonoids, class of plant secondary 
metabolites previously known as vitamin P, have been 
reported to reduce the gene expression and synthesis 
of IL-1β and IL-2 by inactivating NF-κB and activator 
protein-1, two major transcription factors considerably 
involved in cytokines gene expression[89].  
Prevention of osteolysis constitutes the alternative 
mode of intervention, alongside the down-regulation of 
the inflammatory process. For this purpose, osteogenic 
growth factors may be used to locally regulate bone 
configuration and remodeling. BMPs, insulin-like 
growth factors (IGFs), and various TGF-β = a known 
regulator of collagen type Ⅰ represent fundamental local 
regulators of osteogenesis; most significantly these 
growth factors interact with nuclear transcription factors 
(like Core Binding Factor a1) in response to sex steroids, 
glucocorticoids, parathyroid hormone, or PGE2, which 
are all well-known controllers of bone turn-over[91]. 
Hill et al[92] demonstrated that osteoblast survival is 
promoted by IGF-Ⅰ, IGF-Ⅱ, insulin and basic FGF but 
not the PDGF; however, they stated that PDGFs, even 
though they have no direct effect on osteoblast survival, 
they potentiate the survival-promoting effects of IGF-
Ⅰ, IGF-Ⅱ, and insulin. The authors concluded that TNF-
alpha, a monocyte-derived factor, prominently boosts 
cellular apoptosis and may negate the osteoblastogenic 
effects of other unidentified growth factors or 
components of the extracellular matrix. Dobai et al[93] 
established that, in-vitro treatment of osteoblasts with 
1α, 25-(OH)2 vitamin D3 (hormonally active form of 
vitamin D also known as calcitriol) may reverse the 
particle-induced (Ti/Cr/UHMWPE) diminished osteoblast 
function of collagen gene expression and synthesis.
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